Emma Sandgren

Emma Sandgren

Auto-generated profile, based on publicly available information

Emma Sandgren

Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Center+ , P. Debyelaan 25, Maastricht 6229 HX

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2024 in EP Europace
Verified
Journal Article
Open access
PDF file
ESEmma Sandgren
Emma Sandgren
AHAstrid N L Hermans
Astrid N L Hermans
MGMonika Gawałko
Monika Gawałko
KBKonstanze Betz
Konstanze Betz
ASAfzal Sohaib
Afzal Sohaib
Dominik LinzDominik Linz
Dominik Linz
Reduction of atrial fibrillation (AF) burden is the preferred outcome measure over categorical AF rhythm recurrence after AF ablation. In this sub-analysis of the TeleCheck-AF project, we tested the feasibility of smartphone app-based approximation of time spent with AF and/or symptoms. Patients scheduled for at least one teleconsultation during the 12-month follow-up after AF ablation were instructed to use a smartphone photoplethysmography-based application for simultaneous symptom and rhythm monitoring three times daily for 1 week. Proxies of time spent with AF and/or symptoms (% recordings, load, and % days), temporal aggregation of AF and/or symptoms (density), and symptom–rhythm correlation (SRC) were assessed. In total, 484 patients (60% male, 62 ± 9.9 years) were included. Adherence, motivation, and patient satisfaction were high. %AF recordings, AF load, and %AF days (rs = 0.88–0.95) and %symptom recordings, symptom load, and %symptom days (rs = 0.95–0.98) showed positive correlations. The SRC correlated negatively with time spent with symptoms (rs = −0.65–0.90) and with time spent with AF (rs = −0.31–0.34). In patients with paroxysmal AF before ablation and AF during the monitoring period, 87% (n = 39/44) had a low-density score 90% (‘persistent AF pattern’). Corresponding numbers for patients with persistent AF before ablation were 48% (n = 11/23) and 43% (n = 10/23), respectively. On-demand, app-based simultaneous rhythm and symptom assessment provides objective proxies of time spent with AF and/or symptoms and SRC, which may assist in assessing AF and symptom outcomes after AF ablation.

1 June 2021 in Heart Rhythm O2
Verified
Journal Article
Open access
ESEmma Sandgren
Emma Sandgren
AWAnders Wickbom
Anders Wickbom
TKTorbjörn Kalm
Torbjörn Kalm
AAAnders Ahlsson
Anders Ahlsson
NENils Edvardsson
Nils Edvardsson
JEJohan Engdahl
Johan Engdahl
Atrial fibrillation (AF) is common after coronary artery bypass graft (CABG) surgery. To evaluate the incidence and recurrence rate of AF during 1 year after CABG surgery. We also aimed at calculating the AF burden and compare long-term intermittent vs continuous electrocardiogram (ECG) monitoring. Forty patients scheduled for CABG surgery were equipped with an implantable loop recorder (ILR). After discharge, they carried out handheld ECG 3 times daily during the first 30 postoperative days and during 2 weeks at 3 and 12 months. During hospital stay they were monitored with telemetry. Altogether 27 of 40 (68%) patients were diagnosed with AF, 24 during the first month (21 in-hospital and 3 after discharge) and 3 during months 2–12. Three patients progressed into persistent AF. In addition, 17 patients had AF recurrence, 9 of them after the first 30 days. In patients with paroxysmal AF, the AF burden was low, 0.1% (interquartile range [IQR] 0.02%–0.3%). Patients with AF had higher CHA2DS2-VASc scores than non-AF patients: median 4 (IQR 3–4) and 3 (IQR 2–3.5), respectively, P = .006. The handheld ECG identified 45% (9/20) of the patients with AF episodes identified with continuous ECG monitoring with the ILR after discharge from hospital, P = .001. Patients with AF during the postoperative hospitalization showed a high likelihood of recurrent AF, usually within 30 days. Continuous ECG monitoring with an ILR was superior to the handheld ECG for detecting patients with AF. The AF burden was low.

16 December 2021 in Clinical Cardiology
Verified
Journal Article
Open access
PDF file
UWUlla Walfridsson
Ulla Walfridsson
AJAnders Hassel Jönsson
Anders Hassel Jönsson
LKLars O. Karlsson
Lars O. Karlsson
ILIoan Liuba
Ioan Liuba
HAHenrik Almroth
Henrik Almroth
ECEmmanouil Charitakis
Emmanouil Charitakis
Objectives: To investigate the effect of catheter ablation (CA) on symptoms and health‐related quality of life (HRQoL) after 5 years, and analyze predictors of recurrence of symptoms.Background: The primary indication for CA of atrial fibrillation (AF) is to reduce symptoms and improve HRQoL where long‐term follow‐up are sparse.Methods: In this observational, long‐term, single‐center study, patients were recruited from Linköping University Hospital, Sweden. They were aged ≥18 years and had been referred for CA from November 2011 until June 2019. Arrhythmia‐specific symptoms and HRQoL were assessed by patient‐reported outcome measures (PROMs) with the Arrhythmia‐Specific questionnaire in Tachycardia and Arrhythmia (ASTA).Results: In the study were 1521 patients, 69% men, mean age 62 years. At baseline, 87% of the patients and at the 5‐year follow‐up 80% of those eligible filled out the ASTA questionnaire. At follow‐up, 50% reported freedom from symptoms, 18% had >50% symptom reduction, 14% had a minor reduction, while 18% reported no effect or a worsening of symptoms. Factors predicting symptoms were female gender (hazard ratio [HR]: 1.8; 1.2–2.8), body mass index ≥ 35 (HR: 3.9; 1.6–9.8), and ischemic heart disease (IHD) (HR: 2.6; 1.2–5.9). After 5 years, breathlessness during activity, weakness/fatigue, and tiredness were still the most common symptoms; regarding HRQoL they were impaired physical ability and deteriorated life situation.Conclusions and Clinical Implications: This clinical cohort of patients with AF evaluated through PROMs showed that CA had long‐lasting effects on symptoms and HRQoL and that the use of PROMs in clinical routines was feasible. Factors predicting symptoms after CA were female gender, IHD, and obesity, an important reminder to encourage lifestyle management.

13 September 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ESEmma Sandgren
Emma Sandgren
CRCecilia Rorsman
Cecilia Rorsman
NENils Edvardsson
Nils Edvardsson
JEJohan Engdahl Engdahl
Johan Engdahl Engdahl
Silent atrial fibrillation (AF) episodes are common but the role of anticoagulation treatment is under debate. Consecutive patients with dual-chamber pacemakers for sinus node disease or AV block/bundle branch block were retrospectively enrolled and the development of silent AF, any anticoagulation and the incidence of ischaemic stroke and dementia were recorded. In total 411 patients without and 267 with known AF at implant were included. During a median follow-up of 38 months, 30% (125/411) of patients without known AF at implant were diagnosed with silent AF, 62% of those had or were prescribed anticoagulation. Heart failure (p = 0.03) and age >75 years (p = 0.0002) were risk markers for incident silent AF. In patients with known AF at implant, 80% (216/267) were on anticoagulation at implant. The annual stroke incidence was 2.1% in patients with known AF at implant, as compared to 1.9% in patients who developed silent AF during follow-up, and 1.4% in patients without AF. Vascular dementia developed in 11.2% and 6.2% respectively in patients with known AF versus no AF (p = 0.048) as well as in 5.6% of those with silent AF (p = 0.09) The stroke risk in our study population with an incident silent AF diagnosis may have been significantly decreased by the high proportion of anticoagulation treatment. This could imply that without this treatment the stroke risk might have been high enough to justify anticoagulation. Development of vascular dementia was twice as common among patients with known AF as compared to those witht silent AF or no AF. More data is needed to inform the optimal treatment for these patients.

22 August 2025 in EP Europace
Verified
Journal Article
Open access
EREmelie Rakai
Emelie Rakai
FEFarzaneh Etminani
Farzaneh Etminani
NYNinia Younan
Ninia Younan
AAAnton Andersson
Anton Andersson
MAMaria Andersson
Maria Andersson
ESEmma Sandgren
Emma Sandgren
Background and aims: Atrial fibrillation (AF), often asymptomatic and underdiagnosed, is an independent risk factor for ischemic stroke. A knowledge gap remains regarding the optimal target population, and method to use for AF screening. We aimed to test whether screening for AF using a machine learning-based risk-prediction model (RPM) and 14-day continuous patch electrocardiogram (ECG) (Philips ePatch) in high-risk individuals ≥65 years is more effective than standard care. Methods: Individuals ≥65 years were assigned to general or RPM cohort. The general cohort was randomised to control or invitation. In the RPM cohort, high-risk individuals, identified by RPM, were randomised to control or invitation. The primary outcome was six-month AF incidence, analysed as intention-to-invite, comparing RPM + invitation with general + control. Results: Of 2,960 randomised individuals, participation was 43% (632/1480) in invitation arms. AF incidence was higher in RPM + invitation than in general + control arm (3.8%, 28/740 versus 0.7%, 5/740; p<0.001), yielding a risk ratio of 5.6, (95% confidence interval [2.2, 14.4]), and a number needed to invite of 32. AF was more often detected in RPM + invitation than in general + invitation arm (1.1%, 8/740; p<0.001), but not more often than in RPM + control arm (2.2%, 16/740; p=0.07). No difference was found between general + invitation and general + control arms (1.1%, 8/740 versus 0.7%, 5/740; p=0.40). Conclusion: Among high-risk individuals ≥65 years, the combination of a machine learning-based risk-prediction model and long-term ECG recording was superior to standard care in identifying new AF cases.

1 September 2019 in IJC Heart & Vasculature
Verified
Journal Article
Open access
ESEmma Sandgren
Emma Sandgren
CRCecilia Rorsman
Cecilia Rorsman
NENils Edvardsson
Nils Edvardsson
JEJohan Engdahl Engdahl
Johan Engdahl Engdahl
To evaluate the role of baseline 12‑lead ECG in predicting the syncope mechanism during continuous monitoring using an implantable loop recorder (ILR). Consecutive patients with syncope implanted with an ILR were enrolled. Baseline 12‑lead ECG were related to ECG diagnosis derived from ILR tracings recorded at the time of syncope recurrence. In total 300 patients with a mean age of 66 ± 16 years were included, 49% (146/300) received an ILR-guided diagnosis during follow-up. Patients with abnormal baseline ECG more frequently received an ILR-guided diagnosis compared to those with normal baseline ECG 59% vs. 44%, p = 0.018. For a diagnosis of arrhythmic syncope, the corresponding frequencies were 45% vs. 26%, p = 0.001.Patients with bifascicular block significantly more common received an ILR-guided diagnosis 76% (25/33) compared to those with normal baseline ECG 44% (90/205), p ≪ 0.001. In this subgroup, 96% (24/25) were diagnosed with arrhythmic syncope, 23 of which were due to bradyarrhythmia. Bifascicular block occurred almost exclusively among those ≥60 years (31/33). After logistic regression the adjusted OR for arrhythmic syncope was significant for bifascicular block 5.5 (95%CI 2.3-13.2), p ≪ 0.001. PPV for bifascicular block in predicting arrhythmic syncope was 73% and NPV 73%. A baseline 12‑lead ECG with bifascicular block was a strong predictor for syncope during follow-up, most often due to bradyarrhythmia caused by intermittent complete heart block. No other ECG findings were associated with the ILR outcome. We find it reasonable to consider permanent pacing instead of an ILR for patients with bifascicular block and unexplained syncope.